News

Video

Acceptance is Vital to Getting Through Cancer and COVID-19, Says Survivor Ethan Zohn

Author(s):

In an interview with CURE, “Survivor: Africa” winner Ethan Zohn talks about how his cancer journey changed his perspective on life and helps him to navigate the COVID-19 pandemic.

In many ways, former professional soccer player and “Survivor: Africa” winner Ethan Zohn feels that cancer prepared him for the isolation and uncertainty that has been associated with the COVID-19 pandemic. The answer to navigating the chaos, he explained, is to find acceptance.

In a recent interview with CURE®, Zohn opened up about how his experience with a rare form of Hodgkin lymphoma — and the intense treatments he went through to fight it – taught him how to not only deal with isolation but how to find a way to grow beyond it.

Transcript:

CURE: You went through a lot of chemotherapy, radiation, two stem cell transplants. That’s a lot of aggressive treatment, and there’s a lot of isolation that goes with that. Did that experience, in your opinion, make this whole COVID-19, social distancing (that we're slowly coming out of now), did that kind of make it a little bit easier for you or prepare you in any way?

Zohn: I feel like I've been preparing my whole life for this. (Laughs) Like, three times on “Survivor”, 260 days in isolation and like years of (being) socially isolated because of the transplants. You know, this was the life I was living: no crowds, no public places, taxis, can’t eat in restaurants, mask and gloves everywhere you go. That's the life I lived.

And it's interesting because as a cancer patient, I'm protecting myself from the world. And I'm educating people about what's going on with me to try to protect myself from everyone. I think the silver lining, and what's going on right now with this pandemic, is the fact that we are all going through the same thing at the same exact time in some shape.

So, it gets back to that whole thing of just feeling isolated and alone, if you are feeling that, now is the perfect time to lean on the communities now more so than ever before. It's good to lean on community.

And then the other part of that, I think was for me, is just acceptance. The first step to anything you can't control is acceptance. Because all the denial, and this rush to be productive and get things online and take your yoga class. Everything is so organized and prepared in life and we'd like to control things as human beings, but now we can't control anything.

And feeling out of control creates anxiety and uncertainty, and that stuff can cause destructive decisions. So, living in denial is not a good place to be. Of course, I didn't want to accept there was this cancer inside me trying to kill me. But I had to, in order to move on to that next phase, which was, like I said, to map out how I want to live for the rest of this time.

So, I encourage everyone to just try to work on ways to accept what's going on, because then you can map out the next phase of your life, which was important for me.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.